GlassScriptPhysician profile
Chad B Mcbride
NPI 1669677068
$603.21
in general payments reported to CMS, 2019-2025
10 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $17.05 · 2021: $48.74 · 2022: $87.04 · 2023: $133 · 2024: $13.75 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $313.08 | 2019-2025 | Accolade Sr, Farapulse, Watchman Access System |
| Cvrx, INC. | $89.99 | 2021-2023 | Barostim Neo System |
| Abbott Laboratories | $44.96 | 2023-2025 | Mitraclip, Triclip |
| Baxter Healthcare | $43.75 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $25.26 | 2019 | |
| Amgen INC. | $18.61 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.38 | 2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $17.76 | 2019 | |
| Philips North America LLC | $16.72 | 2025 | Azurion 7 M20 |
| Irhythm Technologies, INC. | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.